This is the authors' abstract. We don't add key points for this paper.
OBJECTIVES: Breast cancer is an important leading cause of death from cancer. Stathmin and tau proteins are regulators of cell motility, and their overexpression is associated with the progression and bad prognosis of breast cancer. Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is the potential inhibitor of tau protein in neurons. This study determines the effect of memantine on breast cancer cell migration and proliferation, tau and stathmin gene expression in cancer cells and its synergistic effect with paclitaxel. MATERIALS AND METHODS: transmembrane migration assay. CONCLUSION: The presented data shows that memantine reduced mRNA levels of tau and stathmin proteins and also reduced cellular migration.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Seifabadi et al. (2017) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: